002788.SZ
鹭燕医药
SZSE · Healthcare · F 批发零售 · CN
CNY 10.56
−3.30%Year over year
Reported trailing growth
- Revenue
- +4.5%
- EBITDA
- —
- EBIT
- -15.4%
- EPS
- -16.7%
- Free cash flow
- +3.5%
- Operating cash flow
- -13.7%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +3.0%
- EBITDA
- -4.4%
- EBIT
- -6.7%
- Net income
- -6.6%
- EPS
- -6.8%
- Free cash flow
- -23.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026